Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 18;17(4):523.
doi: 10.3390/ph17040523.

Overview of Research on Leishmaniasis in Africa: Current Status, Diagnosis, Therapeutics, and Recent Advances Using By-Products of the Sargassaceae Family

Fatouma Mohamed Abdoul-Latif  1   2 , Khadija Oumaskour  3 , Nadira Abdallah  1 , Ayoub Ainane  3 , Ibrahim Houmed Aboubaker  4 , Ali Merito  2 , Houda Mohamed  4 , Tarik Ainane  3
Affiliations

Overview of Research on Leishmaniasis in Africa: Current Status, Diagnosis, Therapeutics, and Recent Advances Using By-Products of the Sargassaceae Family

Fatouma Mohamed Abdoul-Latif et al. Pharmaceuticals (Basel). .

Abstract

Leishmaniasis in Africa, which has been designated as a priority neglected tropical disease by various global organizations, exerts its impact on millions of individuals, primarily concentrated within this particular region of the world. As a result of the progressively grave epidemiological data, numerous governmental sectors and civil organizations have concentrated their endeavors on this widespread outbreak with the objective of devising appropriate remedies. This comprehensive examination delves into multiple facets of this parasitic ailment, scrutinizing the associated perils, diagnostic intricacies, and deficiencies within the existing therapeutic protocols. Despite the established efficacy of current treatments, they are not immune to deleterious incidents, particularly concerning toxicity and the emergence of parasitic resistance, thus accentuating the necessity of exploring alternative avenues. Consequently, this research not only encompasses conventional therapeutic approaches, but also extends its scope to encompass complementary and alternative medicinal techniques, thereby striving to identify innovative solutions. A particularly auspicious dimension of this study lies in the exploration of natural substances and by-products derived from some brown algae of the Sargassaceae family. These resources possess the potential to assume a pivotal role in the management of leishmaniasis.

Keywords: Africa; Sargassaceae; diagnosis; leishmaniasis; natural product; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Work methodology.
Figure 2
Figure 2
Life cycle of Leishmania parasites.
Figure 3
Figure 3
Main risk factors.
Figure 4
Figure 4
Conventional and recent diagnostic methods of leishmaniasis.
Figure 5
Figure 5
Main multidimensional approaches for the prevention and control of leishmaniasis.
Figure 6
Figure 6
Main drug treatments for leishmaniasis.
Figure 6
Figure 6
Main drug treatments for leishmaniasis.
Figure 6
Figure 6
Main drug treatments for leishmaniasis.
Figure 7
Figure 7
Mind map of the use of Cystoseira and bifurcaria algae by-products in leishmaniasis treatments (created with www.map-this.com accessed on 10 December 2023).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Soares R.C.R., de Carvalho A.G., Luz J.G.G., Lucas A.L.Z., Ignotti E. Integrated control of neglected tropical diseases in Brazil: Document review of a national campaign in light of WHO recommendations. Rev. Panam. De Salud Pública. 2023;47:e23. doi: 10.26633/RPSP.2023.23. - DOI - PMC - PubMed
    1. Adams I., Kwapong A.A., Boafo E., Twum E., Amponsah S.K. Rising Contagious Diseases: Basics, Management, and Treatments. John Wiley & Sons, Inc.; Hoboken, NJ, USA: 2024. Leishmaniasis: Current Trends in Microbiology and Pharmacology; pp. 297–313.
    1. Kumar V., Madhu M., Murti K. Viral, Parasitic, Bacterial, and Fungal Infections. Academic Press; Cambridge, MA, USA: 2023. An overview on leishmaniasis; pp. 389–406.
    1. Saidi N., Blaizot R., Prévot G., Aoun K., Demar M., Cazenave P.A., Bouratbine A., Pied S. Clinical and immunological spectra of human cutaneous leishmaniasis in North Africa and French Guiana. Front. Immunol. 2023;14:1134020. doi: 10.3389/fimmu.2023.1134020. - DOI - PMC - PubMed
    1. Bamorovat M., Sharifi I., Agha Kuchak Afshari S., Ghasemi Nejad Almani P. Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis. Transbound. Emerg. Dis. 2023;2023:7814940. doi: 10.1155/2023/7814940. - DOI